期刊文献+

异基因造血干细胞移植后肺部感染研究 被引量:1

Study on pulmonary infection following allogeneic hematopoietic stem cell transplantation
下载PDF
导出
摘要 目的:探讨异基因造血干细胞移植术后肺部感染的临床特征及危险因素。方法回顾分析2010~2012年收入该院的37例异基因造血干细胞移植患者的临床资料。结果17例患者异基因造血干细胞移植后发生33例次肺部感染,其中11例患者发生2次及以上的肺部感染,总发生率45.9%,直接死于肺部感染的有5例。仅39.4%(13/33)肺部感染有病原学证据,真菌感染尤其是白假丝酵母菌较为多见。单因素分析显示:肺部感染与供受者人类白细胞抗原(HLA)不全相合、移植物抗宿主病(GVHD)显著相关(P=0.041、0.013),与其他因素无相关性(P>0.05)。多因素分析显示:供受者HLA不全相合及GVHD与肺部感染显著相关(P=0.041、0.021)。结论异基因造血干细胞移植术后肺部感染是常见并发症,对患者威胁较大。HLA不全相合及GVHD与移植后肺部感染显著相关。 Objective To investigate the clinical characteristics and risk factors of pulmonary infection after allogeneic hemato-poietic stem cell transplantation(allo-HSCT) .Methods The clinical data of 37 allo-HSCT patients treated in our transplantation u-nit from 2010 to 2012 were performed the retrospective analysis .Results Among 17 cases of allo-HSCT ,33 case-times of pulmona-ry infection occurred after transplantation ,in which more than twice pulmonary infection occurred in 11 cases ,the total occurrence rate of pulmonary infection was 45 .9% (17/37) .5 cases directly died of pulmonary infection .Only 39 .4% case-times of pulmonary infection had the pathogenic evidence .Fungal infection ,especially Candida albicans ,was predominant .The univariate analysis showed that pulmonary infection was significantly associated with human leucocyte antigen (HLA) non-identical of donor and recip-ient and graft versus host disease(GVHD)(P=0 .041 ,0 .013) ,and had no obvious correlation with the other factors (P>0 .05) . The multivariate analysis showed that the HLA non-identical of donor and recipient and GVHD were significantly associated with the occurrence of pulmonary infection (P=0 .041 ,0 .021) .Conclusion Postoperative pulmonary infection is a common complication following allo-HSCT ,which has larger threat to the patients .HLA non-identical and GVHD are significantly correlated with pulmo-nary infection after allo-HSCT .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第3期278-280,共3页 Chongqing medicine
关键词 造血干细胞移植 感染 移植物抗宿主病 hematopoietic stem cell transplantation lung infection graft vs host disease
  • 相关文献

参考文献12

  • 1Aguilar-Guisado M, Jimfinez-Jambrina M, Espigado I, et al. Pneumonia in allogeneic stem celltransplantation recip~ ients: a multieenter prospective study[J]. Clin Trans- plant,2011,25(6) :629-638.
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3041
  • 3医院获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):201-208. 被引量:2161
  • 4肺结核诊断和治疗指南[J].中国实用乡村医生杂志,2013(2):7-11. 被引量:532
  • 5Sivgin S,Baldane S,Kaynar L,et al. Pretransplant Iron o- verload May be associated with increased risk of invasive fungal pneumonia(IFP) in patients that underwent alloge- neic hematopoietic stem cell transplantation (alloHSCT)[J]. Transfus Apher Sci,2013,48(1) : 103-108.
  • 6Kurosawa M, Yonezumi M, Hashino S, et al. Epidemiolo- gy and treatment outcome of invasive fungal infections in patients with hematological malignancies[J]. Int J Hema- tol,2012,96(6) : 748-757.
  • 7Richardson M, Lass-Flerl C. Changing epidemiology of systemic fungal infections [J]. Clin Mierobiol Infect, 2008,14 Suppl 4:5-24.
  • 8Youssef S, Rodriguez G, Rolston KV, et al. Streptococcus pneumoniae infections in 47 hematopoietic stem cell trans- plantation recipients: clinical characteristics of infections and vaccine-breakthrough infections,1989-2005[J]. Medi- cine,2007,86(2) :69-77.
  • 9Boeckh M,Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients [J]. Blood, 2009, 113(23) :5711-5719.
  • 10Muto T, Takeuchi M, Kawaguchi T, et al. Low-dose trim- ethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT[J]. Bone Marrow Transplant, 2011,46 (12) : 1573- 1575.

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献5620

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部